🔴 Connect Biopharma is trading 11.27% down in pre-market as Nasdaq Composite falls 1.73%

Connect Biopharma is trading 11.27% down at $1.81 after broad pre-market weakness.

• The Nasdaq Composite is down 1.73%, while the S&P 500 is down 0.76%.
• No new company-specific announcement was identified for September 14, 2026; management is scheduled to present at the H.C. Wainwright conference on September 15.
• Investors await September topline results from two Phase 2 Seabreeze STAT studies; the decline follows a 30.07% drop on September 3 and appears primarily tied to risk-off global sentiment.